Position in LAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,568
+$6,368 QoQ
Shares Held
28,742
+53.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 143 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in LAB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $192,998,899 across 51 Medical Devices names. LAB ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in LAB
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,568 | 28,742 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $17,200 | 18,696 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,142 | 11,049 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,311 | 12,547 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $14,316 | 11,930 | Shares | Sole | 2025-08-15 | |
| 2022-06-30 | $1,648 | 1,030 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $3,697 | 1,030 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,037 | 1,030 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,057 | 1,071 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $25,754 | 4,181 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,097 | 4,225 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||